The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer
assess the efficacy and safety of gemcitabine in the maintenance treatment of advanced non-small cell lung cancer
THE Efficacy and Safety of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer
DRUG: gemcitabine
PFS, from the first cycle of treatment (day one) to two month after the last cycle
assess the efficacy and safety of gemcitabine in the maintenance treatment of advanced non-small cell lung cancer